Skip to main navigation Skip to search Skip to main content

ASO Author Reflections: Is There a Relationship Between TIL and Regression in Melanoma?

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)2867-2868
Number of pages2
JournalAnnals of surgical oncology
Volume29
Issue number5
DOIs
StatePublished - May 2022

Funding

JSZ research funding from Amgen, Castle Biosciences, Delcath Systems, Novartis, Provectus and Philogen; medical advisory board for Delcath Systems, speakers’ bureau for Sun Pharma, Pfizer, and consultant for Merck, Sanofi/Regeneron, Amgen, Castle Biosciences. JTV speaker for Castle Biosciences.

Funders
Castle Biosciences
Sanofi/Regeneron
Amgen
Merck

    ASJC Scopus subject areas

    • Surgery
    • Oncology

    Cite this